Physician profile
Shan Huang
NPI 1942659479
$13,762.38
in general payments reported to CMS, 2019-2025
11 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.99 · 2022: $1,534 · 2023: $1,542 · 2024: $444 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Food and Beverage: $2,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,000.00 |
| Food and Beverage | $2,188.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,053.88 | 2025 | |
| Smith+Nephew, INC. | $1,438.36 | 2022-2024 | Collagenase Santyl, Acticoat 4" X 4", Versajet |
| Avita Medical Americas, LLC | $716.72 | 2023 | Recell |
| Davol INC. | $490.42 | 2023-2024 | Phasix Mesh |
| Integra Lifesciences Corporation | $389.47 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $292.82 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Bioventus LLC | $217.76 | 2022-2023 | Sonicone Clinic |
| Prytime Medical Devices, INC. | $84.81 | 2024 | Er-Reboa Plus |
| Polynovo North America LLC | $38.15 | 2023 | |
| Abbvie INC. | $25.41 | 2021 | |
| Sanara Medtech INC. | $14.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shan Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.